Our novel observations, together with previous results from our laboratory showing that TLR3 is upregulated in inflammatory bowel disease [38], strongly indicate that this PRR may indeed play a role in activating the CCL20-CCR6 axis in inflammatory bowel disease. Here, CCL20 is linked to inflammatory bowel disease.